Cargando…
P376: VENO-OCCLUSIVE DISEASE RISK AND OTHER OUTCOMES IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING INOTUZUMAB OZOGAMICIN AND PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANTATION
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428447/ http://dx.doi.org/10.1097/01.HS9.0000968416.51811.f0 |
| _version_ | 1785090471527186432 |
|---|---|
| author | de Lima, Marcos Kebriaei, Partow Lanza, Francesco Cho, Christina Popradi, Gizelle Kaur, Manmeet Zhang, Mei-Jie Zhang, Fan Tikka, Saara Vandendries, Erik Asomaning, Kofi Dorman, Stephanie Stelljes, Matthias Marks, David Saber, Wael |
| author_facet | de Lima, Marcos Kebriaei, Partow Lanza, Francesco Cho, Christina Popradi, Gizelle Kaur, Manmeet Zhang, Mei-Jie Zhang, Fan Tikka, Saara Vandendries, Erik Asomaning, Kofi Dorman, Stephanie Stelljes, Matthias Marks, David Saber, Wael |
| author_sort | de Lima, Marcos |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428447 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104284472023-08-17 P376: VENO-OCCLUSIVE DISEASE RISK AND OTHER OUTCOMES IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING INOTUZUMAB OZOGAMICIN AND PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANTATION de Lima, Marcos Kebriaei, Partow Lanza, Francesco Cho, Christina Popradi, Gizelle Kaur, Manmeet Zhang, Mei-Jie Zhang, Fan Tikka, Saara Vandendries, Erik Asomaning, Kofi Dorman, Stephanie Stelljes, Matthias Marks, David Saber, Wael Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428447/ http://dx.doi.org/10.1097/01.HS9.0000968416.51811.f0 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters de Lima, Marcos Kebriaei, Partow Lanza, Francesco Cho, Christina Popradi, Gizelle Kaur, Manmeet Zhang, Mei-Jie Zhang, Fan Tikka, Saara Vandendries, Erik Asomaning, Kofi Dorman, Stephanie Stelljes, Matthias Marks, David Saber, Wael P376: VENO-OCCLUSIVE DISEASE RISK AND OTHER OUTCOMES IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING INOTUZUMAB OZOGAMICIN AND PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANTATION |
| title | P376: VENO-OCCLUSIVE DISEASE RISK AND OTHER OUTCOMES IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING INOTUZUMAB OZOGAMICIN AND PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANTATION |
| title_full | P376: VENO-OCCLUSIVE DISEASE RISK AND OTHER OUTCOMES IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING INOTUZUMAB OZOGAMICIN AND PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANTATION |
| title_fullStr | P376: VENO-OCCLUSIVE DISEASE RISK AND OTHER OUTCOMES IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING INOTUZUMAB OZOGAMICIN AND PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANTATION |
| title_full_unstemmed | P376: VENO-OCCLUSIVE DISEASE RISK AND OTHER OUTCOMES IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING INOTUZUMAB OZOGAMICIN AND PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANTATION |
| title_short | P376: VENO-OCCLUSIVE DISEASE RISK AND OTHER OUTCOMES IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING INOTUZUMAB OZOGAMICIN AND PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANTATION |
| title_sort | p376: veno-occlusive disease risk and other outcomes in patients with b-cell precursor acute lymphoblastic leukemia receiving inotuzumab ozogamicin and proceeding to hematopoietic stem cell transplantation |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428447/ http://dx.doi.org/10.1097/01.HS9.0000968416.51811.f0 |
| work_keys_str_mv | AT delimamarcos p376venoocclusivediseaseriskandotheroutcomesinpatientswithbcellprecursoracutelymphoblasticleukemiareceivinginotuzumabozogamicinandproceedingtohematopoieticstemcelltransplantation AT kebriaeipartow p376venoocclusivediseaseriskandotheroutcomesinpatientswithbcellprecursoracutelymphoblasticleukemiareceivinginotuzumabozogamicinandproceedingtohematopoieticstemcelltransplantation AT lanzafrancesco p376venoocclusivediseaseriskandotheroutcomesinpatientswithbcellprecursoracutelymphoblasticleukemiareceivinginotuzumabozogamicinandproceedingtohematopoieticstemcelltransplantation AT chochristina p376venoocclusivediseaseriskandotheroutcomesinpatientswithbcellprecursoracutelymphoblasticleukemiareceivinginotuzumabozogamicinandproceedingtohematopoieticstemcelltransplantation AT popradigizelle p376venoocclusivediseaseriskandotheroutcomesinpatientswithbcellprecursoracutelymphoblasticleukemiareceivinginotuzumabozogamicinandproceedingtohematopoieticstemcelltransplantation AT kaurmanmeet p376venoocclusivediseaseriskandotheroutcomesinpatientswithbcellprecursoracutelymphoblasticleukemiareceivinginotuzumabozogamicinandproceedingtohematopoieticstemcelltransplantation AT zhangmeijie p376venoocclusivediseaseriskandotheroutcomesinpatientswithbcellprecursoracutelymphoblasticleukemiareceivinginotuzumabozogamicinandproceedingtohematopoieticstemcelltransplantation AT zhangfan p376venoocclusivediseaseriskandotheroutcomesinpatientswithbcellprecursoracutelymphoblasticleukemiareceivinginotuzumabozogamicinandproceedingtohematopoieticstemcelltransplantation AT tikkasaara p376venoocclusivediseaseriskandotheroutcomesinpatientswithbcellprecursoracutelymphoblasticleukemiareceivinginotuzumabozogamicinandproceedingtohematopoieticstemcelltransplantation AT vandendrieserik p376venoocclusivediseaseriskandotheroutcomesinpatientswithbcellprecursoracutelymphoblasticleukemiareceivinginotuzumabozogamicinandproceedingtohematopoieticstemcelltransplantation AT asomaningkofi p376venoocclusivediseaseriskandotheroutcomesinpatientswithbcellprecursoracutelymphoblasticleukemiareceivinginotuzumabozogamicinandproceedingtohematopoieticstemcelltransplantation AT dormanstephanie p376venoocclusivediseaseriskandotheroutcomesinpatientswithbcellprecursoracutelymphoblasticleukemiareceivinginotuzumabozogamicinandproceedingtohematopoieticstemcelltransplantation AT stelljesmatthias p376venoocclusivediseaseriskandotheroutcomesinpatientswithbcellprecursoracutelymphoblasticleukemiareceivinginotuzumabozogamicinandproceedingtohematopoieticstemcelltransplantation AT marksdavid p376venoocclusivediseaseriskandotheroutcomesinpatientswithbcellprecursoracutelymphoblasticleukemiareceivinginotuzumabozogamicinandproceedingtohematopoieticstemcelltransplantation AT saberwael p376venoocclusivediseaseriskandotheroutcomesinpatientswithbcellprecursoracutelymphoblasticleukemiareceivinginotuzumabozogamicinandproceedingtohematopoieticstemcelltransplantation |